Effect of a genomic classifier on adjuvant treatment decision-making among patients with high-risk pathology at radical prostatectomy: Results from the multicenter prospective PRO-IMPACT study.

John L. Gore,Marguerite du Plessis,Maria Santiago-Jimenez,Kasra Yousefi,Darby J. S. Thompson,David Y.T. Chen,William R. Clark,M. Franks,Lawrence Karsh,Adam S. Kibel,Hyung L. Kim,Brian R. Lane,Yair Lotan,William T. Lowrance,Paul Maroni,Scott David Perrapato,Edouard J. Trabulsi,Robert J. Waterhouse,Elai Davicioni,Daniel W. Lin

Effect of a genomic classifier on adjuvant treatment decision-making among patients with high-risk pathology at radical prostatectomy: Results from the multicenter prospective PRO-IMPACT study.

2016

5053Background: The decision to provide adjuvant therapy to men with high risk pathology after radical prostatectomy (RP) is confounded by tremendous uncertainty. We prospectively evaluated the imp...

Keywords:

Prostatectomy
Adjuvant
Pathology
Physical therapy
Medicine
treatment decision making
Adjuvant therapy
impact study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations